Cargando…

Discovery of novel bacterial topoisomerase I inhibitors by use of in silico docking and in vitro assays

Topoisomerases are important targets for antibacterial and anticancer therapies. Bacterial topoisomerase I remains to be exploited for antibiotics that can be used in the clinic. Inhibitors of bacterial topoisomerase I may provide leads for novel antibacterial drugs against pathogens resistant to cu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sandhaus, Shayna, Chapagain, Prem P., Tse-Dinh, Yuk-Ching
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780498/ https://www.ncbi.nlm.nih.gov/pubmed/29362471 http://dx.doi.org/10.1038/s41598-018-19944-4

Ejemplares similares

Bacterial topoisomerase I as a target for discovery of antibacterial compounds
por: Tse-Dinh, Yuk-Ching
Publicado: (2009)

Inhibition of Zn(II) Binding Type IA Topoisomerases by Organomercury Compounds and Hg(II)
por: Cheng, Bokun, et al.
Publicado: (2015)

The role of the Zn(II) binding domain in the mechanism of E. coli DNA topoisomerase I
por: Ahumada, Adriana, et al.
Publicado: (2002)

Mutation adjacent to the active site tyrosine can enhance DNA cleavage and cell killing by the TOPRIM Gly to Ser mutant of bacterial topoisomerase I
por: Cheng, Bokun, et al.
Publicado: (2008)

Mechanism of Type IA Topoisomerases
por: Dasgupta, Tumpa, et al.
Publicado: (2020)

Residues of E. coli topoisomerase I conserved for interaction with a specific cytosine base to facilitate DNA cleavage
por: Narula, Gagandeep, et al.
Publicado: (2012)

Deacetylation of topoisomerase I is an important physiological function of E. coli CobB
por: Zhou, Qingxuan, et al.
Publicado: (2017)

Direct Observation of Topoisomerase IA Gate Dynamics
por: Mills, Maria, et al.
Publicado: (2018)

Type IA Topoisomerases as Targets for Infectious Disease Treatments
por: Seddek, Ahmed, et al.
Publicado: (2021)

Structural basis for suppression of hypernegative DNA supercoiling by E. coli topoisomerase I
por: Tan, Kemin, et al.
Publicado: (2015)

Inhibition of Mg(2+) binding and DNA religation by bacterial topoisomerase I via introduction of an additional positive charge into the active site region
por: Sorokin, Elena P., et al.
Publicado: (2008)

Biochemical Basis of E. coli Topoisomerase I Relaxation Activity Reduction by Nonenzymatic Lysine Acetylation
por: Zhou, Qingxuan, et al.
Publicado: (2018)

Investigating mycobacterial topoisomerase I mechanism from the analysis of metal and DNA substrate interactions at the active site
por: Cao, Nan, et al.
Publicado: (2018)

The DNA relaxation activity and covalent complex accumulation of Mycobacterium tuberculosis topoisomerase I can be assayed in Escherichia coli: application for identification of potential FRET-dye labeling sites
por: Narula, Gagandeep, et al.
Publicado: (2010)

Analysis of DNA relaxation and cleavage activities of recombinant Mycobacterium tuberculosis DNA topoisomerase I from a new expression and purification protocol
por: Annamalai, Thirunavukkarasu, et al.
Publicado: (2009)

Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors
por: Pal, Sourav, et al.
Publicado: (2019)

Mechanistic insights from structure of Mycobacterium smegmatis topoisomerase I with ssDNA bound to both N- and C-terminal domains
por: Cao, Nan, et al.
Publicado: (2020)

Experimental and computational investigations of Ser10 and Lys13 in the binding and cleavage of DNA substrates by Escherichia coli DNA topoisomerase I
por: Strahs, Daniel, et al.
Publicado: (2006)

Microbial Type IA Topoisomerase C-Terminal Domain Sequence Motifs, Distribution and Combination
por: Diaz, Brenda, et al.
Publicado: (2022)

Microheterogeneity of Topoisomerase IA/IB and Their DNA-Bound States
por: Jeanne Dit Fouque, Kevin, et al.
Publicado: (2019)

Identification of Anziaic Acid, a Lichen Depside from Hypotrachyna sp., as a New Topoisomerase Poison Inhibitor
por: Cheng, Bokun, et al.
Publicado: (2013)

Small DNA circles as bacterial topoisomerase I inhibitors
por: Li, Dawei, et al.
Publicado: (2019)

Resistance to topoisomerase cleavage complex induced lethality in Escherichia coli via titration of transcription regulators PurR and FNR
por: Liu, I-Fen, et al.
Publicado: (2011)

Localization of Mycobacterium tuberculosis topoisomerase I C-terminal sequence motif required for inhibition by endogenous toxin MazF4
por: Garcia, Pamela K., et al.
Publicado: (2022)

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
por: Pu, Yinglan, et al.
Publicado: (2017)

The interaction between transport-segment DNA and topoisomerase IA—crystal structure of MtbTOP1 in complex with both G- and T-segments
por: Ferdous, Shomita, et al.
Publicado: (2022)

Kinetic Study of DNA Topoisomerases by Supercoiling-Dependent Fluorescence Quenching
por: Wang, Yunke, et al.
Publicado: (2019)

Tyrosyl-DNA Phosphodiesterase 1 and Topoisomerase I Activities as Predictive Indicators for Glioblastoma Susceptibility to Genotoxic Agents
por: Wang, Wenjie, et al.
Publicado: (2019)

Machine Learning Models Combined with Virtual Screening and Molecular Docking to Predict Human Topoisomerase I Inhibitors
por: Li, Bingke, et al.
Publicado: (2019)

The Structural Features of Novel Bacterial Topoisomerase Inhibitors That Define Their Activity on Topoisomerase IV
por: Kokot, Maja, et al.
Publicado: (2022)

Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
por: Grossman, Scott, et al.
Publicado: (2023)

Bacterial topoisomerase I and topoisomerase III relax supercoiled DNA via distinct pathways
por: Terekhova, Ksenia, et al.
Publicado: (2012)

Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics
por: Matias-Barrios, Victor M., et al.
Publicado: (2021)

Bulge oligonucleotide as an inhibitory agent of bacterial topoisomerase I
por: Yang, Zhaoqi, et al.
Publicado: (2017)

Discovery of DNA Topoisomerase I Inhibitors with Low-Cytotoxicity Based on Virtual Screening from Natural Products
por: Xin, Lan-Ting, et al.
Publicado: (2017)

Application of a Novel Microtitre Plate-Based Assay for the Discovery of New Inhibitors of DNA Gyrase and DNA Topoisomerase VI
por: Taylor, James A., et al.
Publicado: (2013)

Combination of bioaffinity ultrafiltration-UFLC-ESI-Q/TOF-MS/MS, in silico docking and multiple complex networks to explore antitumor mechanism of topoisomerase I inhibitors from Artemisiae Scopariae Herba
por: Chen, Tong, et al.
Publicado: (2023)

Novel bivalent securinine mimetics as topoisomerase I inhibitors
por: Hou, Wen, et al.
Publicado: (2017)

Identification of Inhibitors against Metastasis Protein “Survivin:” In silico Discovery Using Virtual Screening and Molecular Docking Studies
por: Mishra, Swechha, et al.
Publicado: (2017)

Phase I study of sequentially administered topoisomerase I inhibitor (irinotecan) and topoisomerase II inhibitor (etoposide) for metastatic non-small-cell lung cancer.
por: Ando, M., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_9j77hvggfqa4ucud4bu8odcaeh